Advanced Life Sciences Announces Appointment
of Experienced Local Businessman and Entrepreneur to Board of
Woodridge, Ill, July 16, 2001 - Advanced Life Sciences, Inc.
announced today the appointment of Thomas V. Thornton, to its
Board of Directors. Mr. Thornton is a seasoned early-stage venture
capital investor, recognized leader in public/private technology
development initiatives, and frequent speaker on topics related
to e-commerce, technology entrepreneurship, and technology policy.
"We look forward to Mr. Thornton's participation on the
Advanced Life Sciences Board of Directors," said Dr. Sharon
W. Ayd, Chief Operating Officer of the Company. "Tom Thornton
intuitively knows what it takes to be successful in getting outsiders
to invest in the Company. We expect that we will benefit greatly
from his previous Board experience with other technology startup
Mr. Thornton is the former Managing Partner for Chicago-based
Devine interVentures, inc. where he led seed- and early-stage
venture investing teams that managed over $120 million and contributed
to divine Interventure's Initial Public Offering. He is also Past
President of The Illinois Coalition, a public/private partnership
established to strengthen state economy through science and technology.
Under his leadership, the Coalition coordinated several initiatives
to help Illinois research institutions pursue federal funding
for their research programs. Mr. Thornton was also appointed by
Governor Edgar to serve on the Illinois Science and Technology
Advisory Council and was named by Mayor Daley to serve on the
Mayor's Council of Technology Advisors.
Advanced Life Sciences, Inc., based in Woodridge, Illinois (http://www.advancedlifesciences.com)
is a privately held, early-stage pharmaceutical technology development
company that discovers and develops therapeutic compounds to fight
infection, inflammation and cancer. The company bridges the gap
between academic discoveries and pharmaceutical commercialization
and focuses on conditions that have significant unmet medical
needs in medium sized markets.
# # #